Blog
Discover our latest articles and blogs
8–12 Week Trial: Evidence Backed Supplements for PCOS by Phenotype
Evidence-first PCOS supplement guidance: RCT-backed choices matched to your phenotype and labs, plus how to check dose, interactions, and run an 8–12 week...
Start 250 mg, Consider 600 mg: NMN Dosing Backed by Human Trials
Evidence first nicotinamide mononucleotide dosing: start at 250 mg, step to 600 mg for functional gains if needed, and follow trial tested timing and...
When 1,000 mg Fails: Vitamin C Upper Limit, Absorption, and Label Math
Learn the official 2,000 mg ceiling, how absorption and tissue saturation limit benefit, and simple steps to add food plus supplement totals.
300–600 mg Nitrate: Beetroot Powder Benefits Backed by Trials
Beetroot powder: evidence backed uses for modest BP lowering (2.9 mmHg) and short, intense performance. Practical dosing and label checks.
300–600 mg/hr Sodium Targets for Runners: Test Sweat and Verify Labels
Evidence first electrolyte plan for runners: 300–600 mg/hr sodium targets, a single run sweat test, and a simple label check to verify products before...
Ecdysterone Favored Over Turkesterone in Human Trials; Check Labels
Ecdysterone shows more promising but inconsistent human-trial signals; turkesterone trials show no clear benefit. Many products are underdosed or...
Vitamin D3 and K2 Benefits: Biomarker Gains, Not Proven Outcomes
Evidence review: vitamin D3 plus K2. Trials improve biomarkers but show mixed fracture and heart outcomes. Includes trial dosing and testing
Check Hyperforin: St. John's Wort Interactions That Lower Drug Levels
Which drugs are at risk from St. John's wort, why hyperforin dose matters, and how to verify interactions before you combine medications.
Kava Side Effects: What 93 Case Reports Reveal About Liver Risk
An evidence-first look at kava side effects: common mild reactions like dizziness and sedation, rare liver injuries flagged by FDA and WHO, who should...